Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...

Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Eledon Pharmaceuticals (ELDN – Research Report) today and set a price target ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

After hours: February 7 at 6:26:17 PM EST Loading Chart for TAK ...

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

After hours: February 7 at 6:08:00 PM EST Loading Chart for ICLR ...

“We applaud the companies in TransCelerate BioPharma for joining forces to address a series of longstanding challenges in new drug development. This collaborative approach in the pre-competitive ...

Colombia: President Petro Compares Cocaine To Whiskey, Wants Its Legalised | Firstpost America | N18G In a live-streamed ...

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price decreased by equities research analysts at Leerink Partners from $980.00 to $862.00 in a research note issued on Tuesday.